HISTORY: Formation Ranbaxy was started by Ranbir Singh and Gurbax Singh in 1937 as a distributor for a Japanese company Shionogi. The name Ranbaxy is a combination of the names of its first owners Ranbir and Gurbax. Bhai Mohan Singh bought the company in 1952 from his cousins Ranbir and Gurbax. After Bhai Mohan Singh’s son Parvinder Singh joined the company in 1967‚ the company saw an increase in scale. His sons Malvinder Mohan Singh and Shivinder Mohan Singh sold the company to the Japanese company
Premium Ranbaxy Laboratories Generic drug
allowing the organization to lose its competitive edge. The first thing that Schering-Plough did is bring in a new CEO to turn the company around. The newly assigned CEO Fred Hassan had to implement a global strategy with a global matrix structure that did not the separate the regional groups eliminating the layers between the different country mangers and him (Jones‚ 2013‚ p.235). The CEO has made the right kinds of integration‚ control mechanisms‚
Premium Management Organization Culture
ramifications. The fight was one of the most heavily publicized matches in boxing history and was expected to draw the largest television audience ever. At 32‚ Ali was considered well past his prime‚ having suffered losses in fights against Joe Frazier and Ken Norton. His exile from boxing‚ from 1967 to 1970‚ for refusing induction into
Premium Muhammad Ali Boxing Joe Frazier
Harvard. He was hired by McKinsey & Company as a consultant and in 1987 began working with Enron to help create a forward market in natural gas (wikipedia.org). Ken Lay hired Skilling in 1990 as chairman and chief executive officer of Enron Finance Corp. and in 1991 he became the Chairman of Enron Gas Services Co. Also‚ he was appointed CEO/managing director of Enron Capital & Trade Resources. Skilling was promoted to second highest position in the company‚ president and chief operating officer
Premium Jeffrey Skilling Kenneth Lay Enron
markets in certain US states. It rapidly grew and the world followed suit. It was nominated ‘World’s Most Innovative Large Corporation’ six years in row and valued at 64 times its earnings and 6 times its book value. It had one of the highest paid CEOs in the world in 2000. It led an aggressive and apparently effective expansion model from its creation in 1985‚ as an interstate pipeline operator based in Houston‚ until secret cracks split wide open and the corporation was engulfed in a dramatic implosion
Premium Enron
Since 2000 the Stock market valuation of the ‘Big Pharma’ companies has dropped sharply. Discuss the causes of the pharmaceutical industry’s current problems and steps that companies are taking to tackle them. By Ali Asgar Kagzi In 1990s‚ pharmaceutical companies were one of the leading shareholder value creators at the stock market. By 1998 the P/E ratio of the Big Pharma companies was twice that of the global stock market and there was a sudden rush among the investors to have a share of
Premium Pharmaceutical industry Pharmacology Drug development
recommendations on what could be done in order to resolve the company problems that appeared in Tidewater Corporation. First of all‚ before going into details let me introduce the main characters of the case. They are as follows: Bob Salinger: CEO of Tidewater Corporation Ken Vaughn: Head of Design Department Harold Bass: Head of Human Resources Department Morris Redstone: Reorganization Leader Professionals Connecting Worlds
Premium Case study Communication Organizational studies
The Value of Marginal Places In the essay “In Praise of Margins” by Ian Frazier‚ Frazier mentions that the world is a place where adults tend to get caught up in. They do not realize that what they need is that place to breath. He says that marginal places and activities‚ when he was a kid‚ were a waste of time‚ but once he was older and saw his child have their marginal “moment” playing‚ in the steam instead of fishing‚ he realizes the importance as an adult. He mentions that we all have a place
Premium
Introduction Globally‚ the Indian pharmaceutical industry is ranked third largest in volume terms and 10th largest in value terms. The sector is highly knowledge-based and its steady growth is positively affecting the Indian economy. The organized nature of the Indian pharmaceutical industry is attracting several companies that are finding it viable to increase their operations in the country. The Indian pharmaceutical industry is highly fragmented with about 24‚000 players (330 in the organized
Premium Pharmaceutical industry Generic drug Pharmacology
INTRODUCTION OF PFIZER INC Pfizer‚ Inc. Type Public (NYSE: PFE) Founded Brooklyn‚ New York‚ USA (1849) Headquarters New York City‚ New York‚ USA Key people Jeff Kindler‚ CEO David Shedlarz‚ VC Ian Read‚ Pres. of Pharma. Martin Mackay‚ Pres. of R&D Industry Health Care Products Accupril® Lipitor® Viagra® Revenue ▲$48.613 billion USD (2007) Net income ▲$8.298 billion USD (2007) Employees 106‚000 (2005) Slogan Working for a healthier world™ Website www
Premium Novartis